When did retatrutide start showing effects?

What can the study timeline tell you?

You may feel less hungry before any clear change appears on the scale. Studies tracked two different times: when the drug settled in blood and when weight moved. Those times aren't the same, and neither one promises your timing.

About half of the drug remained after 6 days ^[4]. One weekly shot made the amount in blood fairly steady after 4-5 doses, around weeks 4-5. During stage 2, weight kept changing through 48 weeks, with the fastest change in the first 24 weeks ^[1].

People using unapproved retatrutide on their own often report scale changes in 2-4 weeks. Their amounts aren't checked, so their timing can't be applied to you. No trial has proved those personal accounts.

When did retatrutide reach a steady blood level?

In 2022, a small early study called Phase 1b tracked retatrutide in blood ^[4]. Researchers measured how quickly the blood amount fell. Those findings help explain the dates below for you.

• Time for half the drug to remain: about 6 days. After another 6 days, the amount in blood was roughly half as large again.
• Time until the amount settled: weekly shots made the drug build in blood. With 6-day fading and a 7-day gap, it usually settled after 4-5 shots, around weeks 4-5.
• Amounts raised in steps: The stage 2 studies began lower and increased the amount slowly. That plan aimed to lessen early nausea, diarrhea, or a hunger drop that felt too strong.

The drug begins acting after the first shot, while the amount in blood builds and settles during the first month. Weight kept changing for many more months. This means the first month was not the time of greatest weight loss.

How did weight change over time?

In 2023, the stage 2 obesity study followed 338 people for 48 weeks ^[1]. Staff weighed them often, giving you the group dates below.

• Weeks 1-4: Weight began to differ from placebo, a shot without retatrutide, but the early gap stayed small.
• Weeks 4-16: Weight fell faster as amounts rose and the drug settled in blood. The largest weekly changes came at higher amounts in this span.
• Weeks 16-24: Weight kept falling, while the pulse rise was greatest near week 24 at the highest amount.
• Weeks 24-48: Weight fell more slowly, and the line began to level at higher amounts.
• Week 48: Average weight fell 24.2% at 12 mg, versus 2.1% after placebo.

In 2024, the fatty liver study found an 82.4% liver-fat fall with 12 mg by week 24. At week 48, the fall remained and reached 86.0% ^[5]. Liver fat changed before the final weight check, but that doesn't prove it would always change first for you.

What do people using unapproved retatrutide notice first?

Individual users of unapproved retatrutide wrote these accounts on their own. One set study did not gather them. No trial has checked each account, and the amounts aren't known. They can't predict your result.

People most often describe less hunger and less time spent thinking about food in the first 1-2 weeks. Some notice that before the scale changes, though no study confirms that order.

Many say the scale starts moving in weeks 2-4. Some say it feels faster than with GLP-1-class drugs, which copy a fullness hormone. They guess that glucagon may raise body heat and energy use, but that link remains unproved.

Nausea and bowel trouble also appear in early accounts, mainly in the first 2-4 weeks. Many say the trouble eases, but a trial has not checked each account.

Did the study find a final stopping point?

No firm stopping point appeared in the stage 2 study. Weight was still falling at week 48 in the highest groups, though more slowly after week 24 ^[1]. The 48-week study therefore leaves your longest possible weight change unknown.

Fatty liver followed a different course in the stage 2 study. The large liver-fat fall was present by week 24 and held through week 48 ^[5]. Liver fat may level sooner than weight, but the study can't prove that timing for you.

Studies haven't settled how much weight may return after retatrutide stops. Weight often returns after people stop drugs copying GLP-1, a fullness hormone. The amount may depend on how long treatment lasted and what else changed. TRIUMPH has not published an answer for you.

The retatrutide results page keeps each finding with its study and amount. It can help you separate known dates from guesses, though no study gives a sure personal timeline.